FDA blasts Alkermes for underselling risks of Vivitrol - STAT

FDA blasts Alkermes for underselling risks of Vivitrol - STAT

FDA blasts Alkermes for underselling the risks of opioid addiction drug Vivitrol

By LEV FACHER

CARLA K. JOHNSON/AP

The agency is chastising the Massachusetts drug company Alkermes for “misbranding” Vivitrol, the controversial drug meant to treat opioid addiction.

READ MORE